|
Post by peppy on Feb 14, 2023 11:59:20 GMT -5
2015, 8 years ago. Right after MNKD got the Label, non inferior which meant no health care insurance which meant, short it out of existence. I think that is the way Pharma and the market works in our law/rules framework. Perhaps the NASDAQ has changed the way the real time and summary volumes are collected. The trading has changed. there used to be discrepancies between the two volume collection numbers, now they are running the same. Perhaps when the volume differences between real time and summary volume were there, the option market was being used to cover the shorts. That is my take. I don't think there is much shorting of MNKD in the moment. I know some shorts exist. Case in point, Matt is still gone. poof. Matt had given us the months and year MNKD was going to be bankrupt. Then UTHR and Matt disappeared.
|
|
|
Post by peppy on Feb 14, 2023 9:47:20 GMT -5
MNKD has large volume today. at 15 mins of trade, MNKD volume,
real time, 278,228. summary, 280,744 Avg. Volume 3,916,416
5.45+0.14 (+2.74%) As of 09:46AM EST. Market open.
$5.52 will be a new 52 week high.
weehaw.
MNKD volume At 30 mins of trade, real time, 382,364 summary, 382,753 Avg. Volume 3,916,416
$5.47+0.17 (+3.30%)
Volume at 1 hour of trade, summary, 563,095
$5.42. +0.12
$5.50 was hit.
|
|
|
Post by peppy on Feb 14, 2023 9:29:56 GMT -5
In response to clement above. Thank you Clement.
Clofazimine isn't an approved drug. He was talking about what may be?
The Wealth Wizard.
|
|
|
Post by peppy on Feb 14, 2023 2:08:41 GMT -5
That depends if they ever expect change to come. If not advocating for the change is just self-promotion because they never expect to pay the price. Listen to the last 5 minutes. The “tip of the iceberg” guy whose company specializes in finding indications of misdeeds (which the other guy confirms with intra-day trade forensics) implies a well-known VIP is going to bring it to Congress in a noticeable way. I was hoping he meant Elon Musk. Regardless, we’ll see if/when that happens whether it’s real or has legs. What? If this has to do with Naked shorting do you remember the great financial crisis of 2007-2009. CDO's and all? The naked shorting of broke banks and the rest was off the charts. I would have thought your white Jesus had more basis to act then. You are too funny. Musk is financially buried.
|
|
|
Post by peppy on Feb 14, 2023 0:34:50 GMT -5
Summary • MannKind is positioned for growth with the clofazimine inhalation suspension advancing to a Phase 2/3 study and recognition of NTM infection as a global health concern. • MannKind's innovative direct delivery method to the lungs sets it apart from competitors and reduces systemic toxicity. • They have diversified their product pipeline to reduce reliance on Afrezza.
quote; and reduces systemic toxicity.
I have never read this in the data. The rep can not say this in the physicians office.
The Wealth Wizard is making stuff up. 16 Followers
|
|
|
Post by peppy on Feb 13, 2023 20:28:17 GMT -5
RAA's peak at 2 hours after given subq. The only time that algorithm works well is between the breakfast dose and lunch. Algorithm better not skip a meal. agedhippie , last time you mentioned it, oh pump master you were giving subq per needle after your meals. Same plan of care oh aged one? No CMG..... If that algorithm could have been written Al Mann would have written it. Lane is never getting that algorithm sorted out because absorption is too unpredictable. It wasn't like Al did not try. This is the guy who perfected the solar panel, the pacemaker and the insulin pump. We have afrezza because he knew the insulin was too damn unpredictable for an algorithm. You do know the growing tag line for pump users don't you??? "Dump the pump and get the afrezza" Aged, save your time and money on the pump, just go here and they will help you out insulinsavings.com sayhey24 , aged doesn't use a pump; he just talks about pumps. agedhippieLast he told me, subq with a 5/8" needle after he eats. No pre meal bolus. Aged does get his calcium checked by the physician.
|
|
|
Post by peppy on Feb 13, 2023 16:45:06 GMT -5
My wife has a cousin who's youngest son was diagnosed T1 very early. It aged her. She is one of the few people I've met who had heard about Afrezza before I told them. She was interested in a pediatric trial. This was like 8 years ago. Her son is now a young teenager. He had a pump. Her father, her son's grandfather was also a T1, and wore a pump. He went blind, lost toes, and died from COVID. There are worse things than trying to watch your BG levels and using ultra-fast inhalable human insulin as a tool in the toolbox to better manage health. It doesn't surprise me that she found out about Afrezza. The attitude I have heard (we used to run support groups for partners and parents) is that they feel in some way it's their fault and they will burn themselves out trying to fix it. Our sample may have been biased because these were people motivated (and/or desperate) enough to come to a support group. There are reasons to be optimistic. A lot of the data we see is out of date now because treatments have moved on so far (we no longer use animal insulins or NPH, or [spit] ultralente.) Those insulins dictated your life which is why everyone jumped on RAA. Suddenly you could eat when you wanted to and not when your insulin allowed or demanded it. TIR was just awful which led to the complications years later. The AID pumps are another jump like RAA which is why people want them. Now I can ignore my diabetes between meals and let the system keep everything level. Once Lane Desborough who sayhey talks about gets the algorithm sorted out I won't even have to bother with meals - the system will do that as well and now I can really ignore my diabetes. Oddly the thing that stops me from getting one is that progress is so fast that I don't want to get one that will effectively be obsolete in a couple of years (one reason I find the DIY APS movement attractive.) RAA's peak at 2 hours after given subq. The only time that algorithm works well is between the breakfast dose and lunch. Algorithm better not skip a meal. agedhippie, last time you mentioned it, oh pump master you were giving subq per needle after your meals. Same plan of care oh aged one? No CMG.....
|
|
|
Post by peppy on Feb 13, 2023 16:34:48 GMT -5
As folk songwriter Pete Seeger might sing: “Where Has All The Volume Gone…” The Kinks might sing their rendition too (which Van Halen might later cover)...
|
|
|
Post by peppy on Feb 13, 2023 16:06:49 GMT -5
MNKD Nasdaq real time volume, 1,791,967 shares. MNKD Nasdaq summary volume, 1,765,174 Avg. Volume 3,987,477 $5.30. +0.14. (+2.71%) Charts, MNKD Daily, schrts.co/ewGvRWkV$COMPQ daily, schrts.co/jRWJvemSUTHR daily. schrts.co/hfueeuEa$SPX daily, schrts.co/kIDQqZHX
|
|
|
Post by peppy on Feb 13, 2023 12:21:41 GMT -5
You all know I am at nauseam, so..... Looking at MNKD and $COMPQ charts, etc.... The $COMPQ held 11550 which was my line..... for the pattern target of 13,000 on this retrace. The way I see it this is good news for MNKD share price as the indices going up helps raise the tide for MNKD. Take a look. See the Nasdaq tested and back up? schrts.co/fXZwcvHZ. MNKD following the Nasdaq up, schrts.co/wxHKAebNThese charts are pictures in time. Also, point of break out of the MNKD triangle, $5.90 right above. A six year triangle,....... volume should come in heavy at $5.92, $6.00, $6.25, $6.50 etc. This set up is going to work.... Everyone can see it is in plain site for anyone that looks, also known are the scripts growth and projectory. Bloomberg terminals. Weehaw
|
|
|
Post by peppy on Feb 13, 2023 11:03:04 GMT -5
MNKD share price is traveling up on low volume, presently, $5.24+0.08 (+1.55%) at 1 and 1/2 hours of trade MNKD VOLUME, 334,962 Share price pulling out of a tight consolidation, here are the highs to hit, $5.26, $5.28, $.29, $5.33, $5.34, $5.50, $5.51, the daily highs on this consolidation. schrts.co/FhVfpIdDAdded, at 2 hours of trade, MNKD volume, 489,354 Avg. Volume 3,987,477 5.30+0.14 (+2.71%) Notice the average volume has drop down under 4,000,000 shares.
|
|
|
Post by peppy on Feb 10, 2023 16:11:23 GMT -5
|
|
|
Post by peppy on Feb 9, 2023 16:29:23 GMT -5
|
|
|
Post by peppy on Feb 9, 2023 12:53:56 GMT -5
MNKD volume at the half day of trade, 481,844 shares. Avg. Volume 4,157,931 5.19+0.09 (+1.78%) For my entertainment pleasure I drew the flag on a two hour price chart. schrts.co/dnFMDKktwith this volume the lines may need to be moved, however, a pretty flag.
|
|
|
Post by peppy on Feb 9, 2023 10:32:28 GMT -5
MNKD volume at 1 hour of trade, real time, 171,974 shares. summary, 172,162 Avg. Volume 4,157,931 $5.18. +0.08 (+1.57%) finance.yahoo.com/quote/MNKD?p=MNKDat 2 hours of trade MNKD volume, 313,492 shares. $5.16. +0.07 (+1.27%)
|
|